Anthem Biosciences Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	19,966	18,446	14,194	10,569	12,313	11,032
Other Revenue	58.37	58.37	8	9.82	95.09	21.77
Revenue	20,024	18,504	14,202	10,579	12,408	11,054
Revenue Growth (YoY)	12.68%	30.29%	34.24%	-14.74%	12.24%	-
Cost of Revenue	8,112	7,815	6,254	3,574	4,270	4,637
Gross Profit	11,912	10,689	7,948	7,005	8,137	6,417
Selling, General & Admin	2,718	2,623	1,844	1,540	1,379	1,426
Other Operating Expenses	1,510	1,292	1,039	1,103	982.96	843.76
Operating Expenses	5,478	4,809	3,702	3,280	2,940	2,893
Operating Income	6,434	5,880	4,246	3,725	5,197	3,524
Interest Expense	-52.03	-100.17	-92.76	-82.01	-115.6	-159.99
Interest & Investment Income	647	647	408.62	290.99	95.76	8.45
Currency Exchange Gain (Loss)	73.42	73.42	146.18	128.89	133.26	159.71
Other Non Operating Income (Expenses)	326.24	-2.78	-1.86	223.59	16.62	56.24
EBT Excluding Unusual Items	7,429	6,498	4,706	4,286	5,327	3,588
Gain (Loss) on Sale of Investments	75.78	75.78	71.8	68.97	135.99	69.47
Gain (Loss) on Sale of Assets	-4.64	-4.64	-4.35	-0.03	-1.84	-1.87
Other Unusual Items	-253.71	-	-	618.02	-	-
Pretax Income	7,246	6,569	4,773	4,973	5,461	3,656
Income Tax Expense	2,400	2,056	1,100	1,121	1,406	942.72
Net Income	4,847	4,513	3,673	3,852	4,055	2,713
Preferred Dividends & Other Adjustments	-	-	-	-	-	0.01
Net Income to Common	4,847	4,513	3,673	3,852	4,055	2,713
Net Income Growth	2.30%	22.86%	-4.64%	-5.02%	49.48%	-
Shares Outstanding (Basic)	560	559	567	570	570	547
Shares Outstanding (Diluted)	565	562	567	570	570	547
Shares Change (YoY)	0.54%	-0.96%	-0.61%	-	4.33%	-
EPS (Basic)	8.65	8.07	6.48	6.75	7.11	4.96
EPS (Diluted)	8.58	8.04	6.48	6.75	7.11	4.96
EPS Growth	1.78%	24.11%	-4.03%	-5.04%	43.27%	-
Free Cash Flow	-	1,038	-1,499	1,171	1,771	1,618
Free Cash Flow Per Share	-	1.85	-2.64	2.05	3.10	2.96
Gross Margin	59.49%	57.77%	55.96%	66.21%	65.58%	58.05%
Operating Margin	32.13%	31.78%	29.89%	35.21%	41.89%	31.88%
Profit Margin	24.20%	24.39%	25.86%	36.41%	32.68%	24.54%
Free Cash Flow Margin	-	5.61%	-10.55%	11.06%	14.27%	14.64%
EBITDA	7,368	6,759	5,050	4,358	5,763	4,134
EBITDA Margin	36.80%	36.53%	35.56%	41.19%	46.45%	37.40%
D&A For EBITDA	934.17	878.75	804.85	633.27	566.06	610.8
EBIT	6,434	5,880	4,246	3,725	5,197	3,524
EBIT Margin	32.13%	31.78%	29.89%	35.21%	41.89%	31.88%
Effective Tax Rate	33.12%	31.30%	23.05%	22.54%	25.74%	25.79%
Revenue as Reported	21,152	19,303	14,831	11,340	12,802	11,404
Advertising Expenses	-	15.62	10.62	5.35	1.17	1.18

Source: S&P Global Market Intelligence. Standard template. Financial Sources.